Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
Medical and Pediatric Oncology|January 1, 1985
Phase II study of daunorubicin in previously untreated patients with advanced colorectal carcinomaJ Harvey, E Bonnem, K Grady, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancerC D Blanke, B Kasimis, P Schein, et al.Blood|April 1, 1984
Cellular and molecular mechanisms of the bone marrow sparing effects of the glucose chloroethylnitrosourea chlorozotocinP Byrne, K Tew, J Jemionek, et al.Annals of Internal Medicine|October 1, 1975
Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disordersM Lutzner, R Edelson, P Schein, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neckP Espana, F Smith, J Abrams, et al.Cancer|March 15, 1980
Prognostic factors in Burkitt's lymphoma: importance of total tumor burdenI Magrath, Y J Lee, T Anderson, et al.Lancet (London, England)|February 1, 1975
Advanced diffuse histiocytic lymphoma, a potentially curable diseaseV T DeVita, G P Canellos, B Chabner, et al.Gynecologic Oncology|January 1, 1990
Hexamethylmelamine as a single second-line agent in ovarian cancerA Manetta, C MacNeill, J A Lyter, et al.Cancer Treatment Reviews|March 1, 1991
Analysis of prognostic factors and survival in patients with ovarian cancer treated with second-line hexamethylmelamine (altretamine)A Manetta, C MacNeill, J A Lyter, et al.Oncology|January 1, 1985
Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free stateR Maral, C Bourut, E Chenu, et al.Pageof 3